The constellations overhead in May are dominated by Leo the Lion and Ursa Major the Great Bear. Leo is easy to pick out by spotting a large backward question mark known as the Sickle. The bright star ...

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 ...

Swiss pharmaceutical giant Novartis is poised to expand its profile in the San Diego area, announcing plans to acquire ...

Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.

Fintel reports that on May 1, 2025, Wells Fargo downgraded their outlook for Regulus Therapeutics (NasdaqCM:RGLS) from ...

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

Regulus Therapeutics (RLS) contingent value right may be worth $3-$4 a share in its planned sale to Novartis (NVS), according ...

As May commences, Jupiter, resembling a luminous golden star within the constellation Taurus, shines high above the western ...

Novartis announces acquisition of Regulus Therapeutics, adding a potential first-in-class miR-17 inhibitor for ADPKD to its ...

Jupiter and Mars shine in the evening, more planets gather in the morning, and the Eta Aquariid meteors join in.

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...